This week, the top news in managed care included President Donald Trump's first address to Congress, which included guiding principles for replacing the Affordable Care Act, a leaked version of the House GOP's own draft for healthcare reform, and a study finds a concerning trend in colorectal cancer rates among young adults.
President Trump outlines what he wants from healthcare reform, while House Republicans call for ending Medicaid expansion.
Welcome to This Week in Managed Care, I’m Laura Joszt.
Trump's Joint Address
In his first address before Congress, President Donald Trump said the Affordable Care Act (ACA) is “collapsing” and offered broad ideas on how he would fix it. Trump said any replacement for the current law should do the following:
Said Trump: “Everything that is broken in our country can be fixed.”
House GOP Draft
House Republicans floated a draft bill to repeal parts of the ACA that would go further than Trump.
The bill, which borrows from Speaker Paul Ryan’s plan called A Better Way, would phase out extra funding for those covered by Medicaid expansion, and create a per capita grant system of funding for the entire program.
The bill shares Trump’s call to end the individual mandate and make use of health savings accounts, but it also does the following:
For more on efforts to replace the ACA, visit ajmc.com
President Trump’s message:
House Republican plan:
Higher Rates of Colorectal Cancer
A study from the American Cancer Society finds an alarming trend: colorectal cancer is rising among young adults. A person born in 1990 is 2 times as likely to be diagnosed with colon cancer and 4 times as likely to be diagnosed with rectal cancer than a baby boomer born in 1950.
Said lead author Dr. Rebecca Siegal: “Trends in young people are a bellwhether for the future disease burden. Our finding that colorectal cancer risk for millennials has escalated back to the level of those born in the late 1800s is very sobering.”
While the cause of the trend is not entirely clear, researchers see rising obesity and unhealthy diets, as well as a lack of physical activity, as possible reasons.
Outcomes of In-House Pharmacy
A study from the Smilow Cancer Hospital at Yale finds that bringing a specialty pharmacy in-house can reduce errors and save costs. This is especially true when dispensing oral oncology agents.
The study uncovered several problems with the old drug delivery process, such as:
Today, a new treatment protocol reaches out to patients to monitor adherence. Hospital management has allowed 80% of patients to get their drugs within 72 hours, as opposed to 2 to 3 weeks.
The study will be presented later this year at the annual meeting of the American Society of Clinical Oncology.
ACO Outcomes
A new paper in JAMA Internal Medicine examined how accountable care organizations (ACOs) in Oregon and Colorado affected spending, access, and healthcare utilization.
Colorado created 7 regional care collaborative organizations as part of its Medicaid accountable care reforms, while Oregon moved most Medicaid enrollees into 16 care coordination organizations.
After 2 years, both efforts saw some successes. Oregon showed improvements in one set of measures, but not in a set that evaluated improvements in low-value care. The Colorado system also generated more savings.
Attend the ACO Coalition
To learn more about how ACOs are changing healthcare, join us in Scottsdale, Arizona on May 4th and 5th for the spring meeting of the ACO and Emerging Healthcare Delivery Coalition.
For information and to register, visit the meeting page.
For all of us at the Managed Markets News Network, I’m Laura Joszt. Thanks for joining us.
Dr Dalia Rotstein: Physicians Must Be Aware MS Affects People of All Backgrounds
April 24th 2024Dalia Rotstein, MD, MPH, emphazises the importance of awareness that multiple sclerosis (MS) impacts patients from various backgrounds as clinicians think through ways to improve access to care and research efforts in MS.
Read More
Navigating Health Literacy, Social Determinants, and Discrimination in National Health Plans
February 13th 2024On this episode of Managed Care Cast, we're talking with the authors of a study published in the February 2024 issue of The American Journal of Managed Care® about their findings on how health plans can screen for health literacy, social determinants of health, and perceived health care discrimination.
Listen
Polatuzumab Vedotin and R-CHP Appropriate for Untreated DLBCL
April 24th 2024Population pharmacokinetic and exposure-response analyses revealed a favorable benefit-risk profilane for the treatment combination of polatuzumab vedotin and rituximab, cyclophosphamide, doxorubicin, and prednisone (R-CHP).
Read More
Drs Raymond Thertulien, Joseph Mikhael on Racial Disparities in Multiple Myeloma Care Access
December 28th 2023In the wake of the 2023 American Society of Hematology Annual Meeting and Exposition, Raymond Thertulien, MD, PhD, of Novant Health, and Joseph Mikhael, MD, MEd, FRCPC, FACP, chief medical officer of the International Myeloma Foundation, discussed health equity research highlights from the meeting and drivers of racial disparities in multiple myeloma outcomes.
Listen
What We’re Reading: Abortion Privacy Rules; Alzheimer Drug Hurdles; Nursing Home Staffing Overhaul
April 23rd 2024New health privacy rules aim to protect patients and providers in an evolving abortion landscape; some physicians express concerns about efficacy, risks, and entrenched beliefs in treating Alzheimer disease; CMS addresses longstanding staffing deficits in nursing homes.
Read More
Award-Winning Poster Presentations From AMCP 2024
April 23rd 2024At the Academy of Managed Care Pharmacy (AMCP) 2024 annual meeting, multiple poster presentations concerned with health equity, data collection, glucagon-like peptide-1 agonists, and more were acknowledged for their originality, relevance, clarity, bias, and quality.
Read More